(19)
(11) EP 1 465 990 A2

(12)

(88) Date of publication A3:
22.07.2004

(43) Date of publication:
13.10.2004 Bulletin 2004/42

(21) Application number: 02806841.9

(22) Date of filing: 23.12.2002
(51) International Patent Classification (IPC)7C12N 9/48, C12N 15/00, C12Q 1/37, C12P 21/06, C07H 21/04, C07K 17/00, A61K 38/48
(86) International application number:
PCT/US2002/040924
(87) International publication number:
WO 2003/082184 (09.10.2003 Gazette 2003/41)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 21.12.2001 US 341804 P

(71) Applicant: Biosynexus Incorporated
Gaithersburg, MD 20877 (US)

(72) Inventors:
  • STINSON, Jeffrey, R.
    Brookeville, MD 20833 (US)
  • GRINBERG, Lioubov
    Gaithersburg, MD 20878 (US)
  • LEES, Andrew
    Silver Spring, MD 20910 (US)
  • MOND, James, J.
    Silver Springs, MD 20901 (US)
  • KOKAI-KUN, John, F.
    Frederick, MD 21703 (US)

(74) Representative: Baldock, Sharon Claire et al
BOULT WADE TENNANT,Verulam Gardens70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) TRUNCATED LYSOSTAPHIN MOLECULE WITH ENHANCED STAPHYLOLYTIC ACTIVITY